Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CUV | Sydney | AUD | Delayed | |
CLVLY | OTC Markets | USD | Delayed | |
CLVLF | OTC Markets | USD | Delayed |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Neutral | Sell | Sell |
Technical Indicators | Strong Buy | Strong Buy | BUY | BUY | Strong Sell |
Summary | Strong Buy | Strong Buy | Neutral | Neutral | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Homing Pigeon | 1M | 1 | Mar 24 | ||
Tri-Star Bearish | 5H | 10 | Feb 21, 2024 19:00 | ||
Tri-Star Bearish | 1W | 11 | Dec 24, 2023 | ||
Tri-Star Bearish | 1H | 11 | Feb 21, 2024 20:00 | ||
Tri-Star Bearish | 15 | 11 | Feb 21, 2024 20:15 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
Sydney | 14.57 | 14.57 | 14.63 | 49,264 | -2.80% | AUD | |||
OTC Markets | 9.464 | 0.000 | 0.000 | 133 | -2.99% | USD | |||
OTC Markets | 9.8200 | 0.0000 | 0.0000 | 1,530 | +0.00% | USD |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Barclays | 201.75 | 202.90 | 199.08 | -2.25 | -1.10% | 11.86M | 09:34:37 | ||
AstraZeneca | 11,988.0 | 12,144.0 | 11,960.0 | -38.0 | -0.32% | 223.96K | 09:34:37 | ||
Legal & General | 235.96 | 236.40 | 234.40 | +3.16 | +1.36% | 1.99M | 09:34:39 | ||
Anglo American | 2,525.1 | 2,569.3 | 2,525.0 | -34.9 | -1.36% | 984.54K | 09:34:28 | ||
Rolls-Royce Holdings | 411.10 | 414.90 | 409.20 | +5.40 | +1.33% | 3.29M | 09:34:51 | ||
Lloyds Banking | 51.68 | 52.00 | 51.08 | +0.48 | +0.94% | 21.53M | 09:34:34 | ||
IAG | 178.40 | 179.00 | 176.80 | +2.25 | +1.28% | 2.21M | 09:34:50 | ||
HSBC | 662.30 | 665.50 | 662.30 | +0.40 | +0.06% | 2.08M | 09:34:29 | ||
J Sainsbury | 258.68 | 261.39 | 258.39 | +2.08 | +0.81% | 688.22K | 09:34:55 | ||
BAE Systems | 1,314.00 | 1,330.00 | 1,307.00 | -6.00 | -0.46% | 1.19M | 09:34:51 |
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company’s pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. The company was founded in 1987 and is headquartered in Melbourne, Australia.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review